Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-23

Clinical Trial Update: A Study of the Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the absorption, distribution, metabolism, and elimination of Opevesostat (MK-5684) in healthy adult male participants has completed, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Opevesostat (MK-5684)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Metastatic Prostate Cancer | Phase 1 | Status: COMPLETED